AIGH Capital Management’s PolyPid PYPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.57M Sell
1,246,741
-258,000
-17% -$1.28M 0.66% 28
2026
Q2
$7.64M Sell
1,504,741
-88,846
-6% -$410K 0.48% 26
2026
Q1
$6.98M Buy
1,593,587
+250,615
+19% +$1.11M 0.95% 26
2025
Q4
$5.83M Buy
1,342,972
+277,844
+26% +$1.03M 1.41% 21
2025
Q3
$3.55M Sell
1,065,128
-128,980
-11% -$447K 1% 26
2025
Q2
$4.22M Buy
1,194,108
+253,727
+27% +$743K 1.9% 21
2025
Q1
$2.55M Buy
940,381
+112,514
+14% +$335K 1.06% 28
2024
Q4
$2.51M Buy
827,867
+148,199
+22% +$487K 0.78% 25
2024
Q3
$2.37M Buy
679,668
+200,422
+42% +$720K 0.67% 24
2024
Q2
$2.05M Hold
479,246
– – 0.64% 25
2024
Q1
$2.27M Buy
+479,246
New +$2.9M 0.68% 31

Other funds holding PYPD

AIGH Capital Management's PYPD Position: Q3 2026 in Review

AIGH Capital Management reduced its PolyPid (PYPD) stake by 17% in Q3 2026, selling an estimated $1.28M and leaving 1,246,741 shares worth $6.57M. The position accounts for 0.66% of the portfolio, ranked #28.

AIGH Capital Management first reported a position in PYPD in Q1 2024 and has held it in 11 quarters since. The position peaked at $7.64M in Q2 2026. 6 funds tracked by Wall St. Rank hold PYPD as of Q3 2026.

  • AIGH Capital Management held 1,246,741 shares of PolyPid worth $6.57M as of Q3 2026.
  • AIGH Capital Management sold 258,000 PolyPid shares in Q3 2026, an estimated $1.28M.
  • PolyPid made up 0.66% of AIGH Capital Management's portfolio in Q3 2026, its #28 holding.
  • AIGH Capital Management first reported a position in PolyPid in Q1 2024 and has held it in 11 quarters since.
  • AIGH Capital Management's PolyPid position peaked at $7.64M in Q2 2026.
  • 6 funds tracked by Wall St. Rank held PolyPid as of Q3 2026.

Based on AIGH Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.